Revolution Medicines (RVMD) Return on Capital Employed (2020 - 2026)

Revolution Medicines' (RVMD) quarterly Return on Capital Employed came in at 68.84% in Q1 2026, down 3457.0% year-on-year from 2.05% in Q1 2025, and down 17.19% quarter-over-quarter from 58.74% in Q4 2025.

Revolution Medicines (RVMD) Return on Capital Employed (2020 - 2026) Analysis & Trends

Revolution Medicines' Return on Capital Employed history runs 7 years deep, the most recent figure standing at 68.84% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 3457.0% year-over-year to 68.84% in Q1 2026; TTM through Mar 2026 was 68.84%, a 3457.0% decrease from a year earlier, with the FY2025 full-year figure at 54.59%, down 2246.0% from the prior year.
  • Return on Capital Employed fell to 68.84% in Q1 2026 per RVMD's latest filing, from 58.74% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 29.23% in Q1 2024 and bottomed at 81.79% in Q3 2024.
  • The 5-year median for Return on Capital Employed is 38.03% (2022), against an average of 43.88%.
  • Across the five-year window, Return on Capital Employed sank 4269 bps in 2024 and soared 3230 bps in 2025, its largest moves.
  • Year by year, Return on Capital Employed stood at 34.12% in 2022, then retreated by 4 bps to 35.33% in 2023, then advanced by 2 bps to 34.53% in 2024, then sank by 70 bps to 58.74% in 2025, then declined by 17 bps to 68.84% in 2026.
  • Per Business Quant, the three latest RVMD Return on Capital Employed figures stand at 68.84% (Q1 2026), 58.74% (Q4 2025), and 49.5% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -31.80%
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -107.40%
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 10.46%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 21.10%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 10.19%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -68.84%
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 20.34%

Historic Data

Download Data
DateValue
Mar 31, 2026 -68.84%
Dec 31, 2025 -58.74%
Sep 30, 2025 -49.50%
Jun 30, 2025 -40.56%
Mar 31, 2025 -34.27%
Dec 31, 2024 -34.53%
Sep 30, 2024 -81.79%
Jun 30, 2024 -68.51%
Mar 31, 2024 -29.23%
Dec 31, 2023 -35.33%
Sep 30, 2023 -39.10%
Jun 30, 2023 -32.37%
Mar 31, 2023 -31.02%
Dec 31, 2022 -34.12%
Sep 30, 2022 -38.03%
Jun 30, 2022 -38.05%
Mar 31, 2022 -31.94%
Dec 31, 2021 -27.81%
Sep 30, 2021 -24.08%
Jun 30, 2021 -19.22%